Estrone, sex hormone binding globulin and lipid profiles in older women: an observational study

References

• Scarabin P-Y. Endogenous sex hormones and cardiovascular disease in postmenopausal women: new but conflicting data. Ann Transl Med. 2018;6:23:448.
   PubMed Web of Science ®Google Scholar
• Gorodeski GI. Update on cardiovascular disease in post-menopausal women. Best Pract Res Clin Obstet Gynaecol. 2002;16(3):329–355.
   PubMed Web of Science ®Google Scholar
• Rackley CE. Hormones and coronary atherosclerosis in women. Endocrine. 2004;24(3):245–250.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Hawken S, Ôunpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):953–962.
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801–1811.
   PubMed Web of Science ®Google Scholar
• Maffei L, Murata Y, Rochera V, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol. J Clin Endocrinol Metab. 2004;89:61–70.
   PubMed Web of Science ®Google Scholar
• Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol. 2001;79(1–5):3–9.
   PubMed Web of Science ®Google Scholar
• Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325(17):1196–1204.
   PubMed Web of Science ®Google Scholar
• Darling GM, Johns JA, McCloud PI, et al. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med. 1997;337(9):595–601.
   PubMed Web of Science ®Google Scholar
• Rackley CE. Estrogen and coronary artery disease in postmenopausal women. Am J Med. 1995;99(2):117–118.
   PubMed Web of Science ®Google Scholar
• Davis S, Goldstat R, Newman A, et al. Differing effects of low dose estrogen and progestin replacement therapy and pravastatin in hypercholesterolemic postmenopausal women. Climacteric. 2002;5(4):341–350.
   PubMed Web of Science ®Google Scholar
• Worsley R, Robinson PJ, Bell RJ, et al. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause. 2013;20(6):640–645.
   PubMed Web of Science ®Google Scholar
• Davis SR, Bell RJ, Robinson PJ, et al. Testosterone and estrone increase from the age of 70 years; findings from the sex hormones in older women study. J Clin Endocrinol Metab. 2019;104(12):6291–6300.
   PubMed Web of Science ®Google Scholar
• Robman LD, Guymer RH, Wolfe R, et al. Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly”(ASPREE)-AMD trial. Contemp Clin Trials Commun. 2020;20:100667.
   PubMed Web of Science ®Google Scholar
• Group AI. Study design of ASPirin in reducing events in the elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials. 2013;36(2):555–564.
   PubMed Web of Science ®Google Scholar
• Teng E, Chui H. The modified mini-mental state examination (3MS). Can J Psychiatry. 1987;41(2):114–121.
   Google Scholar
• Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv. 1976;6(3):493–508.
   PubMed Web of Science ®Google Scholar
• Wolfe R, Murray AM, Woods RL, et al. The aspirin in reducing events in the elderly trial: statistical analysis plan. London (UK): SAGE Publications; 2018.
   Google Scholar
• Harwood DT, Handelsman DJ. Development and validation of a sensitive liquid chromatography–tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta. 2009;409(1–2):78–84.
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Hirani V, et al. Temporal trend in androgen status and androgen-sensitive outcomes in older men. J Clin Endocrinol Metab. 2016;101(4):1836–1846.
   PubMed Web of Science ®Google Scholar
• Davis SR, Bell RJ, Robinson PJ, et al. Testosterone and estrone increase from the age of 70 years: findings from the sex hormones in older women study. J Clin Endocrinol Metabol. 2019;104(12):6291–6300.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Ev E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):W-163–W-194.
   Web of Science ®Google Scholar
• Simpson ER, Davis SR. Minireview: aromatase and the regulation of estrogen biosynthesis–some new perspectives. Endocrinology. 2001;142(11):4589–4594.
   PubMed Web of Science ®Google Scholar
• Labrie F, Belanger A, Luu-The V, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids. 1998;63(5–6):322–328.
   PubMed Web of Science ®Google Scholar
• Davis SR, Martinez-Garcia A, Robinson PJ, et al. Estrone is a strong predictor of circulating estradiol in women age 70 years and older. J Clin Endocrinol Metab. 2020;105(9):e3348–e3354.
   PubMed Web of Science ®Google Scholar
• Islam RM, Bell RJ, Handelsman DJ, et al. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial. Lancet Healthy Longev. 2022;3(2):e109–e118.
   PubMedGoogle Scholar
• Laurentino S, Pinto P, Correia S, et al. Structural variants of sex steroid hormone receptors in thetestis: from molecular biology to physiological roles. OA Bioctehnol. 2012;1(2):4.
   Google Scholar
• Bell RJ, Davison SL, Papalia M-A, et al. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause. 2007;14(4):630–638.
   PubMed Web of Science ®Google Scholar
• Bittner V. Non‐high‐density lipoprotein cholesterol: an alternate target for lipid‐lowering therapy. Prev Cardiol. 2004;7(3):122–130.
   PubMedGoogle Scholar
• Kahn S, Hryb D, Nakhla A, et al. Beyond carrier proteins: sex hormone-binding globulin is synthesized in target cells. J Endocrinol. 2002;175:113–120.
   PubMed Web of Science ®Google Scholar
• Ding EL, Song Y, Manson JE, et al. Sex hormone–binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361(12):1152–1163.
   PubMed Web of Science ®Google Scholar
• Bernini GP, Sgro’ M, Moretti A, et al. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab. 1999;84(6):2008–2012.
   PubMed Web of Science ®Google Scholar
• Reinecke H, Bogdanski J, Woltering A, et al. Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol. 2002;90(4):364–368.
   PubMed Web of Science ®Google Scholar
• Lapidus L, Lindstedt G, Lundberg P, et al. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem. 1986;32(1 Pt 1):146–152.
   PubMed Web of Science ®Google Scholar
• Davis SR, Robinson PJ, Moufarege A, et al. The contribution of SHBG to the variation in HOMA‐IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women. Clin Endocrinol. 2012;77(4):541–547.
   PubMed Web of Science ®Google Scholar
• Statistics Abo. Reflecting a nation: stories from the 2011 Census, 2012–2013; [cited 2022 Oct 11]. Available from: https://www.abs.gov.au/ausstats/[email protected]/lookup/2071.0main + features902012-2013.
   Google Scholar
• Wolfe R, Murray AM, Woods RL, et al. The aspirin in reducing events in the elderly trial: statistical analysis plan. Int J Stroke. 2018;13(3):335–338.
   PubMed Web of Science ®Google Scholar